BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Diabetes mellitus
,
Liver
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
lasofoxifene
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
GREB1
MYBL1
SGK3
ARHGEF28
AGR2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
FISCHER_DREAM_TARGETS
KOBAYASHI_EGFR_SIGNALING_24HR_DN
DODD_NASOPHARYNGEAL_CARCINOMA_DN
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Breast cancer MCF-7 cells treated with selective estrogen receptor modulators
Explore Curated Studies Results
Literature
Most Relevant Literature
Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal o…
Selective estrogen receptor modulator (SERM) lasofoxifene forms reactive quinones similar to estradi…
Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) trial: 5-year gynecological o…
Lasofoxifene: selective estrogen receptor modulator for the prevention and treatment of postmenopaus…
Lasofoxifene: Evidence of its therapeutic value in osteoporosis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With…
The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation
Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo o…
Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Canc…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ